Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5 ; volume:24 ; number:1 ; day:8 ; month:8 ; year:2024 ; pages:1-8 ; date:12.2024
BMC infectious diseases ; 24, Heft 1 (8.8.2024), 1-8, 12.2024
- Urheber
-
Molina, Kyle C.
Webb, Brandon J.
Kennerley, Victoria
Beaty, Laurel E.
Bennett, Tellen D.
Carlson, Nichole E.
Mayer, David A.
Peers, Jennifer L.
Russell, Seth
Wynia, Matthew K.
Aggarwal, Neil R.
Ginde, Adit A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-024-09708-z
- URN
-
urn:nbn:de:101:1-2410272110216.286941440423
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Molina, Kyle C.
- Webb, Brandon J.
- Kennerley, Victoria
- Beaty, Laurel E.
- Bennett, Tellen D.
- Carlson, Nichole E.
- Mayer, David A.
- Peers, Jennifer L.
- Russell, Seth
- Wynia, Matthew K.
- Aggarwal, Neil R.
- Ginde, Adit A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary
Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience
Remdesivir: A Review in COVID-19
Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned
Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir
Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians’ perspectives
Real-world predictors of divorce among outpatients with bipolar disorder: sex differences and clinical implications
Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects
Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary
Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience
Remdesivir: A Review in COVID-19
Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned
Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir
Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians’ perspectives
Real-world predictors of divorce among outpatients with bipolar disorder: sex differences and clinical implications
Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects
Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary
Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience
Remdesivir: A Review in COVID-19
Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned
Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir
Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians’ perspectives
Real-world predictors of divorce among outpatients with bipolar disorder: sex differences and clinical implications